AIAxiosabout 17 hours ago
How AI is supercharging drug development
3 min read
A TD Cowen survey of 80 biopharma leaders finds AI compressing preclinical drug development costs and timelines by as much as 70%. The technology is fueling demand for software, sequencing tools, and computer models to accelerate experimental treatments over the next five years.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
